CD147-high classical monocytes: a cellular biomarker for COVID-19 disease severity and treatment response
CD147hi cMono are the primary cellular source of S1-induced inflammatory cytokines and may serve as potential biomarkers for monitoring COVID-19 severity and treatment response.
Authors
- Teruaki Murakami
- Yuko Yoshimine
- Atsushi Kumanogoh (ORCID: https://orcid.org/0000-0003-4749-7117)
- Shinichiro Nameki (ORCID: https://orcid.org/0000-0003-3716-4554)
- Yasutaka Okita (ORCID: https://orcid.org/0000-0003-3620-8412)
- Yoshito Takeda (ORCID: https://orcid.org/0000-0003-2905-6537)
- Saori Amiya
- Takayoshi Morita (ORCID: https://orcid.org/0000-0002-7111-9506)
- Yuta Yamaguchi (ORCID: https://orcid.org/0000-0002-8314-9294)
- Haruhiko Hirata (ORCID: https://orcid.org/0000-0002-1134-7283)
- Yasuhiro Kato (ORCID: https://orcid.org/0000-0002-4050-2350)
Institutions
- Japan Agency for Medical Research and Development (JP)
- Osaka University Hospital (JP)
- Kobe University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Inflammation and Regeneration
- Published
- 2025-04-07
- DOI
- https://doi.org/10.1186/s41232-025-00371-8
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Japan Agency for Medical Research and Development
- Kansai Economic Federation
- Ministry of Education, Culture, Sports, Science and Technology
- Japan Society for the Promotion of Science
- Center of Innovation Program